- Home
- MCO vs ELV Comparison
MCO vs ELV Comparison
Compare MCO & ELV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MCO
- ELV
- Stock Information
- Founded
- MCO 1900
- ELV 1944
- Country
- MCO United States
- ELV United States
- Employees
- MCO N/A
- ELV N/A
- Industry
- MCO Finance: Consumer Services
- ELV Medical Specialities
- Sector
- MCO Finance
- ELV Health Care
- Exchange
- MCO Nasdaq
- ELV Nasdaq
- Market Cap
- MCO 90.4B
- ELV 78.4B
- IPO Year
- MCO 2000
- ELV N/A
- Fundamental
- Price
- MCO $512.75
- ELV $289.10
- Analyst Decision
- MCO Buy
- ELV Buy
- Analyst Count
- MCO 15
- ELV 15
- Target Price
- MCO $539.79
- ELV $416.86
- AVG Volume (30 Days)
- MCO 763.6K
- ELV 3.1M
- Earning Date
- MCO 07-23-2025
- ELV 07-17-2025
- Dividend Yield
- MCO 0.73%
- ELV 2.37%
- EPS Growth
- MCO 16.16
- ELV N/A
- EPS
- MCO 11.75
- ELV 23.39
- Revenue
- MCO $7,307,000,000.00
- ELV $189,254,000,000.00
- Revenue This Year
- MCO $5.81
- ELV $11.19
- Revenue Next Year
- MCO $8.08
- ELV $7.29
- P/E Ratio
- MCO $43.66
- ELV $12.36
- Revenue Growth
- MCO 11.47
- ELV 10.21
- 52 Week Low
- MCO $378.71
- ELV $274.40
- 52 Week High
- MCO $531.93
- ELV $567.26
- Technical
- Relative Strength Index (RSI)
- MCO 64.26
- ELV 32.54
- Support Level
- MCO $480.59
- ELV $279.76
- Resistance Level
- MCO $518.48
- ELV $296.64
- Average True Range (ATR)
- MCO 9.06
- ELV 11.46
- MACD
- MCO 0.46
- ELV -4.16
- Stochastic Oscillator
- MCO 84.88
- ELV 19.26
About MCO Moody's Corporation
Moody's, along with S&P Ratings, is a leading provider of credit ratings on fixed-income securities. The ratings segment, Moody's Investors Service, includes corporates, structured finance, financial institutions, and public finance ratings. MIS represents a majority of the firm's profit and about half of the firm's revenue. The other segment, Moody's Analytics, consists of decision solutions, research and insights, and data and information.
About ELV Elevance Health Inc.
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 46 million medical members as of December 2024. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states through government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.